ACURA PHARMACEUTICALS, INC
DelistedCIK 786947fmd_0Q9QYZNA8AJCA3SSSYM3B1TMKGManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Dec 31, 2021, 49 periods
Latest annual · FY2021
Millions- Total revenues
- 2
- Operating income
- (1)
- Net income
- (1)
Latest quarter · Q4 FY2021
Millions- Total revenues
- 0
- Operating income
- (0)
- Net income
- 0
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2018 to FY2021
- +56.2%
- Revenue, 5 yearsFY2016 to FY2021
- -18.9%
- Net income, 5 yearsFY2016 to FY2021
- n/m
ACURA PHARMACEUTICALS, INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Revenue | $1.6 million | $3.6 million | -56.2% | 10-K 2023-06-30 · proof |
| Operating income | -$1.2 million | -$758,000 | 10-K 2023-06-30 · proof | |
| Net income | -$879,000 | -$1.2 million | 10-K 2023-06-30 · proof | |
| Cash from operating activities | -$742,000 | -$719,000 | 10-K 2023-06-30 · proof | |
| Total assets | $860,000 | $1.7 million | -50.5% | 10-K 2023-06-30 · proof |
| Total liabilities | $682,000 | $7.6 million | -91.1% | 10-K 2023-06-30 · proof |
| Cash and cash equivalents | $65,000 | $413,000 | -84.3% | 10-K 2023-06-30 · proof |
- What was ACURA PHARMACEUTICALS, INC's revenue in fiscal 2021?
- ACURA PHARMACEUTICALS, INC reported revenue of $1.6 million for fiscal 2021 (the year ended Dec 31, 2021), against $3.6 million the year before (-56.2%). Source: the 10-K filed with the SEC on Jun 30, 2023. SEC
- What was ACURA PHARMACEUTICALS, INC's operating income in fiscal 2021?
- ACURA PHARMACEUTICALS, INC reported operating income of -$1.2 million for fiscal 2021 (the year ended Dec 31, 2021), against -$758,000 the year before. Source: the 10-K filed with the SEC on Jun 30, 2023. SEC
- What was ACURA PHARMACEUTICALS, INC's net income in fiscal 2021?
- ACURA PHARMACEUTICALS, INC reported net income of -$879,000 for fiscal 2021 (the year ended Dec 31, 2021), against -$1.2 million the year before. Source: the 10-K filed with the SEC on Jun 30, 2023. SEC
- What was ACURA PHARMACEUTICALS, INC's cash from operating activities in fiscal 2021?
- ACURA PHARMACEUTICALS, INC reported cash from operating activities of -$742,000 for fiscal 2021 (the year ended Dec 31, 2021), against -$719,000 the year before. Source: the 10-K filed with the SEC on Jun 30, 2023. SEC
- What are ACURA PHARMACEUTICALS, INC's total assets?
- As of Dec 31, 2021, ACURA PHARMACEUTICALS, INC reported total assets of $860,000, against $1.7 million a year earlier (-50.5%). Source: the 10-K filed with the SEC on Jun 30, 2023. SEC
- What are ACURA PHARMACEUTICALS, INC's total liabilities?
- As of Dec 31, 2021, ACURA PHARMACEUTICALS, INC reported total liabilities of $682,000, against $7.6 million a year earlier (-91.1%). Source: the 10-K filed with the SEC on Jun 30, 2023. SEC
- What are ACURA PHARMACEUTICALS, INC's cash and cash equivalents?
- As of Dec 31, 2021, ACURA PHARMACEUTICALS, INC reported cash and cash equivalents of $65,000, against $413,000 a year earlier (-84.3%). Source: the 10-K filed with the SEC on Jun 30, 2023. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:786947&period_type=annual&limit=5"Information only, not investment advice.